Abstract:Considering the challenge that cognitive dysfunction and dementia represent to health is imperative to prioritize early diagnosis strategies and explore the pathophysiological mechanisms. There is no consensus on specific markers and physical tests that indicate cognitive decline in older. The objective of this study was to evaluate a panel of inflammatory biomarkers and physical function and investigate their association with cognitive function in community-dwelling older women. Seventy-one participants were included in this study. Cognitive function was assessed by Mini Mental State Examination, muscle strength using dynamometer, body composition using Dual X-ray absorptiometry, respiratory muscle strength using manuvacuometer, and physical function using the Short Physical Performance Battery and Time Up and Go (TUG) tests. Blood samples were collected to analyze a panel of inflammatory biomarkers. The cognitive function was associated with TUG (β = − 0.48; 95%IC = − 0.54 to − 0.21; p < 0.001), inspiratory muscle strength (β = 0.30; 95%IC = 0.005–0.03; p = 0.009), and leptin concentrations (β = 0.32; 95% IC = 0.001–0.006; 0.007). Time spent on TUG test and leptin levels accounted for 27% of variability in cognitive function independent of age. Poorer physical function with leptin plasma levels is associated with decreased cognitive function in older women. These findings contribute to comprehension of pathophysiology underlying cognitive decline and informing the development of new approaches to prevent, diagnose, monitoring and treat cognitive decline in aging.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the associations between cognitive function, physical function tests and inflammatory biomarkers, especially among community - dwelling elderly women. The main objective of the study is to assess the cognitive function of elderly women and examine its relationship with a series of physical function test results and inflammatory biomarker levels. Specifically, the researchers hope to provide new insights and methods for the early diagnosis, monitoring and treatment of cognitive decline by analyzing the associations between these factors. The research background points out that cognitive impairment and dementia pose significant challenges to health, so it is particularly important to prioritize early diagnosis strategies and explore their pathophysiological mechanisms. However, at present, there is no consensus on specific markers and physical tests that can indicate cognitive decline in the elderly. To fill this knowledge gap, this study explored the relationships between a set of inflammatory biomarkers and physical functions and the cognitive function of community - dwelling elderly women by evaluating them. The study found that cognitive function was associated with Time Up and Go (TUG) test time (\(\beta = - 0.48; 95\% \text{CI}=-0.54 \text{ to } - 0.21; p < 0.001\)), inspiratory muscle strength (\(\beta = 0.30; 95\% \text{CI}=0.005 \text{ to } 0.03; p = 0.009\)) and serum leptin concentration (\(\beta = 0.32; 95\% \text{CI}=0.001 \text{ to } 0.006; p = 0.007\)). TUG test time and leptin levels, independent of age factors, explained 27% of the variation in cognitive function. Poor physical function and higher serum leptin levels were associated with cognitive decline in elderly women. These findings contribute to understanding the pathophysiological basis of cognitive decline and provide new ideas for the prevention, diagnosis, monitoring and treatment of cognitive decline in the elderly.

Cognitive function is associated with performance in time up and go test and with leptin blood levels in community-dwelling older women